ArticleCell transplantation

Safety and preliminary efficacy of allogeneic umbilical cord-derived mesenchymal stem cells administered via the hepatic artery in patients with liver cirrhosis: A phase I open-label trial.

Liem Thanh Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.